Previously, studies have utilized inflammatory markers such as C-reactive protein, white blood cell counts, Tumor Necrosis Factor-alpha, interleukins, and hs-CRP to assess inflammation in myocardial infarction, which is closely associated with cardiovascular event risk, disease severity, and prognosis17. This evidence concerns the gene CRP and myocardial infarction.